Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Trading Statement

21 Apr 2020 07:00

RNS Number : 2674K
Dialight PLC
21 April 2020
 

Dialight plc

("Dialight" or "the Group")

 

COVID-19 UPDATE

 

Dialight plc (LSE: DIA.L), the global leader in sustainable LED lighting for industrial applications, is today issuing the following update on the impact of COVID-19 on the business, its trading and outlook.

Our people and our facilities

The health, safety and well-being of our people remains the first priority. We are supporting our teams fully, whilst following all applicable government health advice and directives.

Our Mexican manufacturing facilities remained operational until last week, though with a reduction in headcount due to the social distancing measures that, in line with government guidelines, we had put in place. We have now voluntarily suspended manufacturing operations, pending the review of our application to the Mexican government for an "essential business" order. We believe that a significant proportion of our manufacturing operations should qualify due to the number of critical infrastructure and medical equipment customers we have.

Our Malaysian manufacturing facility has been closed since 17 March 2020. Whilst most Malaysian manufacturing operations are not expected to re-open until after 28 April 2020, given the government's directive, we have also applied for an "essential business" order and are awaiting a decision.

To date, component supply has been resilient, but we are monitoring supply chains closely.

Current Trading

Order intake during Q1 was in line with our expectations until the latter part of March where we saw some softening in Lighting.

- Whilst the US project business has softened, MRO orders increased substantially, improving our overall order intake in our largest end market.

- Our smaller EMEA business has been significantly impacted due to governments' actions across northern Europe.

- APAC orders have been more resilient with an uptick in the Australian mining sector.

- The components business has seen robust trading with a significant increase in orders to supply parts for medical equipment. We are working through supply chain challenges to deliver these critical components on a timely basis.

Management actions

The Group has acted decisively to reduce costs with all discretionary spend curtailed. The Board and executive team are taking a 20% reduction in salaries and the Chairman forgoing all fees, until the immediate crisis is over.

Regretfully, we have also had to furlough a number of employees and have taken additional salary reductions across the majority of our employees. All capital expenditure on new products has been paused temporarily while we evaluate which projects will derive the highest return when the crisis is over.

Financial position

Net debt at 20 April 2020 was £16.2 million compared to £16.5 million at 31 December 2019. The company remains focused on strict cash management and continues to unwind working capital with good progress being made on reducing inventory levels.

The Group renewed its bank financing in February 2020 with a committed revolving credit facility of £25.0m to February 2023 plus a two-year option. The facility is provided by HSBC UK Bank PLC. We are in early stage discussions with HSBC to arrange additional liquidity and covenant headroom, should that be required.

Outlook

The Group faces a background of short-term increased uncertainty and challenges in the global economy. It is thus more difficult to provide guidance on FY2020 performance, but our current expectations for the 2020 half year and 2020 full year have significantly reduced since the time of our 2019 full year results announcement. We continue to closely monitor and adapt to all developments whilst focusing on meeting customer demands and managing cash tightly. 

Dialight's long term prospects remain excellent given the ongoing conversion to industrial LED lighting. The key industries that we operate within are critical to society, including: utility companies, waste water companies and those in power generation and food and beverage, amongst others. Longer term, we are confident Dialight is well positioned to grow profitability.

 

Contacts:

Dialight plc

Tel: +44 (0)203 058 3542

Fariyal Khanbabi - Group Chief Executive

Tel: +44 (0)203 058 3542

Ronan Sheehy - Interim Group Finance Director

 

About Dialight:

Dialight (LSE: DIA.L) is a global leader in sustainable LED lighting for industrial applications. Dialight's LED products are providing the next generation of lighting solutions that deliver reduced energy consumption and create a safer working environment. Our products are specifically designed to provide superior operational performance, reliability and durability, reducing energy consumption and ongoing maintenance and achieving a rapid return on investment.

The company is headquartered in the UK with operations in the USA, UK, Germany, Malaysia, Singapore, Australia, Mexico, Dubai and Brazil. www.dialight.com.

 

Notes:

1. Cautionary Statement: This announcement contains certain statements, statistics and projections that are or may be forward-looking. The accuracy and completeness of all such statements, including, without limitation, statements regarding the future financial position, strategy, projected costs, plans and objectives for the management of future operations of Dialight plc and its subsidiaries is not warranted or guaranteed. These statements typically contain words such as 'intends', 'expects', 'anticipated', 'estimates' and words of similar import. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. Although Dialight plc believes that the expectations will prove to be correct. There are a number of factors, many of which are beyond the control of Dialight plc, which could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements.

2. This announcement contains inside information (in relation to the financial impact on the Group of the Covid-19 pandemic) for the purposes of article 7 of EU Regulation 596/2014.

3. The Group's interim results are expected to be published in early August 2020.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAELEAFAEEAA
Date   Source Headline
25th Sep 20245:03 pmRNSDirector/PDMR Shareholding
25th Sep 20247:00 amRNSSanmina Litigation
24th Sep 20247:00 amRNSSanmina Litigation
23rd Sep 202412:31 pmRNSResult of AGM
16th Sep 20247:00 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSDirector/PDMR Shareholding
19th Aug 202410:13 amRNSNotice of AGM
16th Aug 20246:10 pmRNSNotice of AGM
12th Aug 20247:00 amRNSDirector/PDMR Shareholding
1st Aug 20247:00 amRNSDirectorate Change
31st Jul 20243:27 pmRNSAnnual Financial Report
30th Jul 20247:00 amRNSFinal Results
29th Jul 20245:34 pmRNSChange of Registered Office
29th Jul 20247:00 amRNSNon-core disposal
23rd Jul 20247:30 amRNSSanmina Litigation
13th Jun 20247:00 amRNSUpdate Announcement
7th May 20247:00 amRNSTotal Voting Rights
19th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 202411:00 amRNSAdmission of New Shares
12th Mar 20245:55 pmRNSHolding(s) in Company
12th Mar 20244:56 pmRNSHolding(s) in Company
26th Feb 20242:39 pmRNSDirector/PDMR Shareholding
19th Feb 20249:16 amRNSDirectorate Change
19th Feb 20247:00 amRNSStatement re second interim results
16th Feb 20247:00 amRNSDirectorate Change
30th Jan 20247:00 amRNSCFO Appointment
30th Jan 20247:00 amRNSTrading Update
2nd Jan 20247:00 amRNSSanmina Litigation
29th Nov 20231:04 pmRNSSanmina Litigation
7th Nov 20235:40 pmRNSHolding(s) in Company
7th Nov 20235:24 pmRNSHolding(s) in Company
7th Nov 20233:52 pmRNSHolding(s) in Company
1st Nov 202312:03 pmRNSPDMR Shareholding
1st Nov 202311:50 amRNSTotal Voting Rights and Capital
1st Nov 202311:15 amRNSBlock listing Interim Review
31st Oct 20234:32 pmRNSHolding(s) in Company
27th Oct 202312:05 pmRNSResults of General Meeting
4th Oct 202311:52 amRNSCirc re. Related Party Transaction
27th Sep 20237:00 amRNSResult of Equity Issue
26th Sep 20235:07 pmRNSREX Retail Offer
26th Sep 20235:05 pmRNSProposed Placing and Retail Offer
18th Sep 202312:25 pmRNSStatement re Update on Financing
18th Sep 20237:00 amRNSDirector Change
18th Sep 20237:00 amRNSUnaudited Half Year Results 2023
26th Jun 20237:00 amRNSDirectorate Change and Notice of Results
8th Jun 20237:00 amRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSDirectorate Changes
16th May 20235:47 pmRNSResult of AGM
16th May 20237:00 amRNSAGM Trading Update
27th Apr 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.